From: Applicability of polygenic risk scores in endometriosis clinical presentation
β (95% CI) | p-value | |
---|---|---|
Weighted PRS | ||
AXIN1 | − 1795.904 (− 4967.744 to 1375.936) | 0.267 |
TRAb | − 2.496 (− 9.756 to 4.764) | 0.500 |
ST1A1 | 7.033 (− 16.464 to 30.529) | 0.557 |
CXCL9 | 14.556 (− 1.168 to 30.280) | 0.070 |
OSM | 7.276 (− 9.965 to 24.518) | 0.408 |
MCP-1 | 1.713 (− 8.026 to 11.452) | 0.730 |
TNFRSF9 | 4.951 (− 3.882 to 13.785) | 0.272 |
Unweighted PRS | ||
AXIN1 | − 190.936 (− 512.742 to 130.871) | 0.245 |
TRAb | 0.224 (− 0.760 to 1.209) | 0.655 |
ST1A1 | 0.485 (− 1.896 to 2.384) | 0.690 |
CXCL9 | 1.239 (− 0.358 to 2.837) | 0.128 |
OSM | 0.831 (− 0.908 to 2.570) | 0.349 |
MCP-1 | 0.074 (− 0.910 to 1.059) | 0.882 |
TNFRSF9 | 0.433 (− 0.461 to 1.327) | 0.342 |